Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(CSE: NEON )

N/A UNCHANGED
Last Price Updated: 3:59 PM EST, Dec 13, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about NEON

NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows
Partnered with SRx Health Solutions and BioScript Solutions to Build Out a Network of NeonMind-branded Specialty Mental Health Clinics Across Canada OAKVILLE, ON / ACCESSWIRE / April 12, 2022 /... 
From NeonMind Biosciences Inc.
Via AccessWire
NeonMind to Present at H.C. Wainwright 2nd Annual Psychedelics Virtual Conference
VANCOUVER, BC / ACCESSWIRE / December 2, 2021 / NeonMind Biosciences Inc. (CSE:NEON) (OTCQB:NMDBF) (FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate NEO-001
- FDA feedback provides clear clinical path for NEO-001, the first obesity drug therapy focused on neuropharmacological and behavioral changes for sustainable weight loss - Company plans to file an IND... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
NeonMind to Participate in Panel Discussion at Lift & Co. Expo's Psychedelics Business Summit on November 19, 2021
VANCOUVER, BC / ACCESSWIRE / November 17, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company, is... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
NeonMind and SRx Health Solutions Announce Strategic Alliance to Establish Specialty Mental Health Clinics for Interventional Psychiatry Treatments
VANCOUVER, BC / ACCESSWIRE / November 8, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company, today... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Biosciences Named as a Top Industry Innovator in Inaugural Issue of Psychedelia Magazine
Announces Participation in Microdose's Wonderland: Miami on November 8-9, 2021 VANCOUVER, BC / ACCESSWIRE / November 5, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind"),... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Advances Strategy for Specialty Clinic Launch
Company expects to launch first specialty clinic locations by early 2022 NeonMind-branded specialty mental health clinics to bring innovative interventional psychiatry treatments to underserved... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD.
Company Continues to Expand Its Scientific Expertise with Noted Expert in Utilizing Ketamine for Treatment Resistant Depression VANCOUVER, BC / ACCESSWIRE / September 22, 2021 / NeonMind Biosciences... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board
Company Broadens Scientific Expertise with Addition of Mental Health Expert in Setting Up and Managing Interventional Psychiatric Clinics VANCOUVER, BC / ACCESSWIRE / September 16, 2021 / NeonMind... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Announces Divestiture of Consumer Related and Other Non-Core Assets
Reflects Strategic Focus on Psychedelic Treatments with Major Milestones in 2021 VANCOUVER, BC / ACCESSWIRE / September 13, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF)... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment Conference
VANCOUVER, BC / ACCESSWIRE / September 8, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind''or the "Company"), an integrated drug development and wellness company focused on... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Announces DTC Eligibility
VANCOUVER, BC / ACCESSWIRE / August 25, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Receives Health Canada Approval for its Functional Mushroom Formulation 'Mindful Blend'
VANCOUVER, BC / ACCESSWIRE / August 17, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Announces Corporate Update and Strategic Reorganization of its Pharmaceutical Division
- Designed to Accelerate Execution of Integrated Drug Development Plan for NEO-001 to Treat Obesity - Establishes R&D Advisory Board, Appoints Philippe Martin as Chairman - Expands Regulatory... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Dr. Sagar Parikh, MD Appointed to NeonMind Specialty Clinics Advisory Board
VANCOUVER, BC / ACCESSWIRE / July 28, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Provides Integrated Drug Development Plan Update for NEO-001 to Treat Obesity
- Target Product Profile and Clinical Phase 1/2 Study Aim To Address Deficiencies In Chronic Weight Management - Pre-IND Meeting in the U.S. and Pre-CTA Consultation Meeting in Canada Targeted for... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Announces Launch of Functional Mushroom Coffees as Dietary Supplements in the US
VANCOUVER, BC / ACCESSWIRE / June 29, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), a psychedelic drug development company, is pleased to announce... 
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
NeonMind to Present at H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference
Vancouver, British Columbia--(Newsfile Corp. - June 14, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FSE: 6UF) ("NeonMind" or... 
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Announces Vitasave Will Carry NeonMind Functional Mushroom Products
Vancouver, British Columbia--(Newsfile Corp. - June 10, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FSE: 6UF) ("NeonMind"), is... 
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
NeonMind to Commence Trading on the OTCQB Venture Market
Vancouver, British Columbia--(Newsfile Corp. - May 28, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FFE: 6UF) ("NeonMind"), an... 
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
NeonMind Announces Creation of Medical Clinics Advisory Board to Guide Planning and Operation of Company-Branded Clinics Across Canada
Vancouver, British Columbia--(Newsfile Corp. - May 26, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (OTC Pink: NMDBF) (FSE: 6UF) ("NeonMind"),... 
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
NeonMind to Present at the Benzinga Global Small Cap Conference
Vancouver, British Columbia--(Newsfile Corp. - May 10, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (OTC Pink: NMDBF) (FSE: 6UF) ("NeonMind"... 
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
BTV Explores Investment Options in Life Sciences
Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - On national TV Sat. May 8 & Sun. May 9, 2021... 
Via Newsfile
Exposures COVID-19
NeonMind Announces New Specialty Clinics Division to Deliver Innovative Mental Health Services, Appoints New VP, Corporate Development
Vancouver, British Columbia--(Newsfile Corp. - April 22, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (OTC PINK: NMDBF) (FFE: 6UF) ("NeonMind"),... 
Via Newsfile
Topics Death Intellectual Property
Exposures COVID-19 Death Intellectual Property
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.